Trial
NCT01397734
Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
National Institutes of Health (NIH); Teva Pharmaceuticals USA
Condition
Chronic Myelogenous Leukemia
Intervention
Arsenic trioxide
Why stopped
Lack of enrollment and limited funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-06